Askleon is developing non-invasive therapies using unique electrical stimulation technology that reduces inflammation, cardiac injury and other benefits in the cardiovascular space.

Askleon’s Values Statement

We are dedicated to maximizing company value by creating innovative cardiovascular therapies and treatment methods.

Our focus is on optimizing patient safety, enhancing therapy efficacy, and ensuring robust data collection, all aimed at achieving efficient and positive patient outcomes.

We strive to develop these advancements in a cost-efficient manner, ensuring that our solutions are accessible and sustainable.

Transcutaneous Electrical Stimulator:

A device that activates the target area from multiple electrodes using a painless local electrode.

About us

ASKLEON LLC.,

1. Development and manufacturing of medical devices

2. Consulting for medical and healthcare equipment

Our team

We are a diverse group of professionals with extensive experience in medical device development.

Hiroyuki Imabayashi

CEO

30 plus years with Olympus Corporation with extensive experience in the development of medical and bio-related equipment.  

Co-founed Adriakaim Corporation in 2018 to develop trans vascular nerve stimulator system. 

Co-founded Askleon Corporation in 2024.

Tsutom (Tom) Abe

COO

More than 25 years as general counsel and 10 plus years experience as the head of BD and alliance management in bio pharma start ups.

CAO at Adriakaim Corporation from 2018 to 2022. 

Co-founded Askleon Corporation in 2024

Gary Sterling

CSO

Over 30 years of cardiovascular medical device experience, including sales management, executive experience and Board of Directors.

Contact us

If you have any questions, you can always contact us at this address.

info@askleon.co.jp